A review of ssri-induced indifference

References

2. Sedgwick P. R. D. Laing: Self, Symptom and Society. Salmagundi. 1971 (16):5-37. Available from: JSTOR

3. Boyce PM. Emotional blunting and depression: symptom or side effect? 2015.

4. Barnhart W, Makela EH, Latocha MJ. SSRI-induced apathy syndrome: A clinical review. Journal of Psychiatric Practice [Literature Review]. 2004 May;10(3):196-199. Available from: PsycINFO

5. Sansone RA, Sansone LA. SSRI-induced indifference. Psychiatry (Edgemont). 2010 October;7(10):14-18. Available from: Embase

6. Singh J. Critical appraisal skills programme. Journal of pharmacology and Pharmacotherapeutics. 2013;4(1):76.

7. Raskin J, George T, Granger RE, Hussain N, Zhao GW, Marangell LB. Apathy in currently nondepressed patients treated with a SSRI for a major depressive episode: Outcomes following randomized switch to either duloxetine or escitalopram. Journal of Psychiatric Research. 2012 May;46(5):667-674. Available from: Embase

8. Corruble E, de Bodinat C, Belaidi C, Goodwin GM. Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: A 24-wk randomized, controlled, double-blind trial. International Journal of Neuropsychopharmacology [Clinical Trial; Empirical Study; Quantitative Study]. 2013 Nov;16(10):2219-2234. Available from: PsycINFO

9. Salvador A, Vinckier F, Meyniel F, Deakin J, Harmer C, Montejo A, et al. Effects of agomelatine compared to escitalopram on motivation in healthy male and female volunteers after 9 weeks of treatment. European College of Neuropsychopharmacology, Berlin. 2014.

10. Furlan PM, Kallan MJ, Ten Have T, Lucki I, Katz I. SSRIs do not cause affective blunting in healthy elderly volunteers. The American journal of geriatric psychiatry. 2004;12(3):323-330.

11. McCabe C, Mishor Z, Cowen PJ, Harmer CJ. Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biological Psychiatry [Empirical Study; Quantitative Study]. 2010 Mar;67(5):439-445. Available from: PsycINFO

12. Bell S, Shipman M, Bystritsky A, Haifley T. Fluoxetine treatment and testosterone levels. Annals of Clinical Psychiatry. 2006 01 Jan;18(1):19-22. Available from: Embase

13. Goodwin G, Price J, De Bodinat C, Laredo J. Emotional blunting with antidepressant treatments: A survey among depressed patients. Journal of Affective Disorders [Empirical Study; Quantitative Study]. 2017 Oct;221:31-35. Available from: PsycINFO

14. Wongpakaran N, van Reekum R, Wongpakaran T, Clarke D. Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: A case-control study. Annals of General Psychiatry. 2007;6 (no pagination). Available from: Embase

15. Kajanoja J, Scheinin NM, Karukivi M, Karlsson L, Karlsson H. Is antidepressant use associated with difficulty identifying feelings? A brief report. Experimental & Clinical Psychopharmacology [Controlled Clinical Trial

Research Support, Non-U.S. Gov't]. 2018 02;26(1):2-5. Available from: MEDLINE

16. Read J, Williams J. Adverse effects of antidepressants reported by a large international cohort: Emotional blunting, suicidality, and withdrawal effects. Current Drug Safety. 2018;13(3):176-186. Available from: Embase

17. Fava M, Graves LM, Benazzi F, Scalia MJ, Iosifescu DV, Alpert JE, et al. A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. The Journal of clinical psychiatry. 2006;67(11):1754-1759.

18. Yee A, Chin SC, Hashim AHB, Harbajan Singh MKAP, Loh HS, Sulaiman AH, et al. Anhedonia in depressed patients on treatment with selective serotonin reuptake inhibitor anti-depressant—a two-centered study in Malaysia. International journal of psychiatry in clinical practice. 2015;19(3):182-187.

19. Marazziti D, Baroni S, Dell’Osso L European Neuropsychopharmacology: ELSEVIER SCIENCE BV PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS p. S447-S447

20. Price J, Cole V, Goodwin GM. Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study. The British Journal of Psychiatry. 2009;195(3):211-217.

21. Opbroek A, Delgado PL, Laukes C, McGahuey C, Katsanis J, Moreno FA, et al. Emotional blunting associated with SSRI-induced sexual dysfunction. Do SSRIs inhibit emotional responses? International Journal of Neuropsychopharmacology [Clinical Trial

Research Support, U.S. Gov't, P.H.S.]. 2002 Jun;5(2):147-51. Available from: MEDLINE

22. Aydemir EO, Aslan E, Yazici MK. SSRI Induced Apathy Syndrome.

23. Zahodne LB, Bernal-Pacheco O, Bowers D, Ward H, Oyama G, Limotai N, et al. Are selective serotonin reuptake inhibitors associated with greater apathy in Parkinson's disease? Journal of Neuropsychiatry & Clinical Neurosciences [Research Support, N.I.H., Extramural

Research Support, Non-U.S. Gov't]. 2012;24(3):326-30. Available from: MEDLINE

24. Popovic D, Vieta E, Fornaro M, Perugi G. Cognitive tolerability following successful long term treatment of major depression and anxiety disorders with SSRi antidepressants. Journal of Affective Disorders. 2015 01 Mar;173:211-215. Available from: Embase

25. Dell'Osso B, Benatti B, Altamura AC, Hollander E. Prevalence of Selective Serotonin Reuptake Inhibitor-Related Apathy in Patients with Obsessive Compulsive Disorder. Journal of Clinical Psychopharmacology [Letter]. 2016 01 Dec;36(6):725-726. Available from: Embase

26. George MS, Trimble MR. A fluvoxamine-induced frontal lobe syndrome in a patient with comorbid Gilles de la Tourette's syndrome and obsessive compulsive disorder. The Journal of clinical psychiatry. 1992.

27. Nazar BP, Hiluy J, Mattos P. Antidepressant induced excessive yawning and indifference. Jornal Brasileiro de Psiquiatria [Clinical Case Study]. 2015 Jan-Mar;64(1):82-85. Available from: PsycINFO

28. De Berardis D, Valchera A, Fornaro M, Serroni N, Marini S, Moschetta FS, et al. Agomelatine reversal of escitalopram-induced apathy: A case report. Psychiatry and Clinical Neurosciences [Letter]. 2013 April;67(3):190-191. Available from: Embase

29. Hoehn-Saric R, Lipsey JR, McLeod DR. Apathy and indifference in patients on fluvoxamine and fluoxetine. Journal of Clinical Psychopharmacology [Empirical Study]. 1990 Oct;10(5):343-345. Available from: PsycINFO

30. Monga V, Padala PR. Aripiprazole for treatment of apathy. Innovations in clinical neuroscience. 2015;12(9-10):33.

31. Bertschy G, Baumann P. Vulnerability to fluoxetine-induced indifference syndrome among opiate addicts: A case report. Biological Psychiatry [Clinical Case Study; Empirical Study]. 1995 Sep;36(6):404-406. Available from: PsycINFO

32. Garland E, Baerg EA. Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents. Journal of Child and Adolescent Psychopharmacology [Clinical Case Study; Empirical Study]. 2001 Sum;11(2):181-186. Available from: PsycINFO

33. Reinblatt SP, Riddle MA. Selective serotonin reuptake inhibitor-induced apathy: A pediatric case series. Journal of Child and Adolescent Psychopharmacology. 2006 February/April;16(1-2):227-233. Available from: Embase

34. Padala PR, Padala KP, Monga V, Ramirez DA, Sullivan DH. Reversal of SSRI-associated apathy syndrome by discontinuation of therapy. Annals of Pharmacotherapy. 2012 March;46(3):e8. Available from: Embase

35. Sato S, Asada T. Sertraline-induced apathy syndrome. Journal of Neuropsychiatry and Clinical Neurosciences [Letter]. 2011;23(1):E19. Available from: Embase

36. Kodela S, Venkata PD. Antidepressant induced apathy responsive to dose reduction. Psychopharmacology Bulletin. 2010;43(4):76-79. Available from: Embase

37. Minsky M. The emotion machine: Commonsense thinking, artificial intelligence, and the future of the human mind. Simon and Schuster; 2007.

38. Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry research. 1991;38(2):143-162.

39. Hoskin R. The dangers of self-report. Science Brainwaves. 2012.

40. Fadnes LT, Taube A, Tylleskär T. How to identify information bias due to self-reporting in epidemiological research. The Internet Journal of Epidemiology. 2009;7(2):28-38.

41. Barsky AJ, Saintfort R, Rogers MP, Borus JF. Nonspecific medication side effects and the nocebo phenomenon. Jama. 2002;287(5):622-627.